HIV and AIDS Trial, Recruiting NCT04704648 Sponsor: AIDS Malignancy Consortium Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT04704648
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a suspected non-spreading eye surface growth on one eye, where a specialist doctor has assessed that it can be surgically removed with a small clear margin around it, without affecting certain surrounding eye structures — this assessment must happen within 4 weeks before the surgery.
  • People who are HIV-positive, confirmed through official medical documentation such as prescription records, HIV test results, or other approved testing methods.
  • People whose general physical health and ability to carry out daily activities falls within an acceptable range on a standard medical scale (confirm with trial site).

Who may not be able to join:

  • People who have taken part in another experimental medical study, or received another experimental treatment (other than an experimental HIV medication), within 30 days before joining this trial.
  • People who have a known history of growths or other conditions affecting the surface of the eye, including previous eye surface tumours, pterygium (a tissue growth on the eye), or a specific chronic eye allergy condition affecting the eye surface.
  • People who have had an uncontrolled serious illness, ongoing active infection, or a mental health or personal situation in the 4 weeks before joining that would make it difficult to follow the trial's requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
AIDS Malignancy Consortium
Registry
ClinicalTrials.gov
Start date
21 June 2023
Est. completion
30 December 2027

Where this trial is recruiting

Uganda

Primary endpoints

Satisfaction of 3 feasibility criteria across all participants and satisfaction of the feasibility criteria by at least 3 of 4 of the participating centers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov